Systemic MCP1/CCR2 blockade and leukocyte specific MCP1/CCR2 inhibition affect aortic aneurysm formation differently

Atherosclerosis

Volumn 211, Issue 1, 2010, Pages 84-89

  de Waard, Vivian ^a,b   Bot, Ilze ^a   de Jager, Saskia C A ^a   Talib, Sara ^a   Egashira, Kensuke ^c   de Vries, Margreet R ^d   Quax, Paul H A ^d   Biessen, Erik A L ^e   van Berkel, Theo J C ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c KYUSHU UNIVERSITY   (Japan)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Aneurysm; CCR2; Leukocytes; MCP1; STAT5

Indexed keywords

APOLIPOPROTEIN E; CHEMOKINE RECEPTOR CCR2; LENTIVIRUS VECTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; SMALL INTERFERING RNA; STAT5 PROTEIN;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; ELECTROPORATION; GENE OVEREXPRESSION; GENE TRANSFER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; WOUND HEALING; ANIMAL; ANTAGONISTS AND INHIBITORS; AORTIC ANEURYSM, ABDOMINAL; DEFICIENCY; DRUG EFFECTS; LEUKOCYTE; METABOLISM; PATHOLOGY;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; CHEMOKINE CCL2; LEUKOCYTES; MICE; RECEPTORS, CCR2; RNA, SMALL INTERFERING; STAT5 TRANSCRIPTION FACTOR; WOUND HEALING;

EID: 77954314066     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.01.042     Document Type: Article

References (22)

1. Guo J., de Waard V., Van Eck M., et al. Repopulation of apolipoproteinE knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development. Arterioscler Thromb Vasc Biol 2005, 25(5):1014-1019.
2. Saederup N., Chan L., Lira S.A., Charo I.F. Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis. Circulation 2008, 117(13):1642-1648.
3. Ashton H.A., Gao L., Kim L.G., et al. Fifteen-year follow-up of a randomized clinical trial of ultrasonographic screening for abdominal aortic aneurysms. Br J Surg 2007, 94(6):696-701.
4. Mastracci T.M., Cinà C.S. Canadian Society for Vascular Surgery. Screening for abdominal aortic aneurysm in Canada: review and position statement of the Canadian Society for Vascular Surgery. J Vasc Surg 2007, 45(6):1268-1276.
5. Hackam D.G., Thiruchelvam D., Redelmeier D.A. Angiotensin-converting enzyme inhibitors and aortic rupture: population-based case-control study. Lancet 2006, 368(9536):659-665.
6. Ishibashi M., Egashira K., Zhao Q., et al. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 2004, 24(11):e174-178.
7. Kitamoto S., Egashira K. Gene therapy targeting monocyte chemoattractant protein-1 for vascular disease. J Atheroscler Thromb 2002, 9(6):261-265.
8. Bot I., Guo J., Van Eck M., et al. Lentiviral shRNA-silencing of murine bone marrow cell CCR2 leads to persistent knockdown of CCR2 function in vivo. Blood 2005, 106(4):1147-1153.
9. Eefting D., Bot I., de Vries M.R., et al. Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice. J Vasc Surg 2009, 50(July (1)):152-160.
10. Daugherty A., Manning M.W., Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000, 105(June (11)):1605-1612.
11. Van Eck M., Herijgers N., Yates J., et al. Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis. Arterioscler Thromb Vasc Biol 1997, 17(11):3117-3126.
12. Schaefer B.C., Schaefer M.L., Kappler J.W., Marrack P., Kedl R.M. Observation of antigen-dependent CD8+ T-cell/dendritic cell interactions in vivo. Cell Immunol 2001, 214(2):110-122.
13. Eefting D., Grimbergen J.M., de Vries M.R., et al. Prolonged in vivo gene silencing by electroporation-mediated plasmid delivery of small interfering RNA. Hum Gene Ther 2007, 18(9):861-869.
14. Daugherty A., Manning M.W., Cassis L.A. Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 2001, 134(4):865-870.
15. Biswas S.K., Sodhi A. Tyrosine phosphorylation-mediated signal transduction in MCP-1-induced macrophage activation: role for receptor dimerization, focal adhesion protein complex and JAK/STAT pathway. Int Immunopharmacol 2002, 2(July (8)):1095-1107.
16. Schepers A., Eefting D., Bonta P.I., et al. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo. Arterioscler Thromb Vasc Biol 2006, 26(9):2063-2069.
17. Egashira K., Nakano K., Ohtani K., et al. Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys. Arterioscler Thromb Vasc Biol 2007, 27(12):2563-2568.
18. Guo J., Van Eck M., Twisk J., et al. Transplantation of monocyte CC-chemokine receptor 2-deficient bone marrow into ApoE3-Leiden mice inhibits atherogenesis. Arterioscler Thromb Vasc Biol 2003, 23(3):447-453.
19. Kundumani-Sridharan V., Wang D., Karpurapu M., et al. Suppression of activation of signal transducer and activator of transcription-5B signaling in the vessel wall reduces balloon injury-induced neointima formation. Am J Pathol 2007, 171(October (4)):1381-1394.
20. Xanthoulea S., Thelen M., Pöttgens C., et al. Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice. PLoS One 2009, 4(7):e6113.
21. Schecter A.D., Berman A.B., Yi L., et al. MCP-1-dependent signaling in CCR2(-/-) aortic smooth muscle cells. J Leukoc Biol 2004, 75(6):1079-1085.
22. MacTaggart J.N., Xiong W., Knispel R., Baxter B.T. Deletion of CCR2 but not CCR5 or CXCR3 inhibits aortic aneurysm formation. Surgery 2007, 142(2):284-288.